Pierre Saintigny logo Academic Members logo

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)


Pierre Saintigny is a medical oncologist and physician-scientist trained at the University Of Paris School Of Medicine. He completed his training as a postdoctoral fellow and clinical fellow in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas M.D. Anderson Cancer Center, Houston, TX where he got his first faculty position as an Assistant Professor. Since 2013, he is serving the Organization of European Cancer Institutes (OECI)-accredited comprehensive Cancer Centre Léon Bérard in Lyon, France. He is affiliated to the Department of Medical Oncology, the Department of Translational Research and Innovation and the Cancer Research Center of Lyon (CRCL). He is focusing his research on the lung and head and neck field and involved in the development of precision medicine through his active participation to the Worldwide Innovative Network (WIN) Association and to the French large scale sequencing program Plan France Médecine Génomique 2025.

Pierre Saintigny logo

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)


Academic Members logo

Pierre Saintigny is a medical oncologist and physician-scientist trained at the University Of Paris School Of Medicine. He completed his training as a postdoctoral fellow and clinical fellow in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas M.D. Anderson Cancer Center, Houston, TX where he got his first faculty position as an Assistant Professor. Since 2013, he is serving the Organization of European Cancer Institutes (OECI)-accredited comprehensive Cancer Centre Léon Bérard in Lyon, France. He is affiliated to the Department of Medical Oncology, the Department of Translational Research and Innovation and the Cancer Research Center of Lyon (CRCL). He is focusing his research on the lung and head and neck field and involved in the development of precision medicine through his active participation to the Worldwide Innovative Network (WIN) Association and to the French large scale sequencing program Plan France Médecine Génomique 2025.


Why WIN